Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive isocyanate species are highly electrophilic chemical entities containing the -N=C=O functional group, primarily recognized as potent environmental toxicants and reactive metabolic intermediates rather than therapeutic targets (PubChem). In pharmacology, they are notably generated during the decomposition of nitrosourea-based chemotherapeutics like carmustine, where they contribute to cytotoxicity by carbamoylating proteins and inhibiting DNA repair mechanisms (StatPearls, 2023). Biologically, these species readily form covalent adducts with endogenous proteins like albumin, acting as haptens that can induce a robust immune response, leading to conditions such as occupational asthma and hypersensitivity pneumonitis (Redlich, 2010). Their biological impact is driven by their ability to irreversibly modify lysine residues and other nucleophilic sites, leading to enzyme inhibition and cellular stress (Menges et al., 2012). Consequently, they represent a major safety concern in industrial settings and a source of secondary toxicity in specific medical treatments.
Reactive isocyanate species act as potent electrophiles that undergo nucleophilic attack by functional groups on proteins (such as lysine amines or cysteine thiols) and nucleic acids, leading to covalent carbamoylation (Menges et al., 2012). This process can inhibit enzyme function, disrupt cellular homeostasis, and create neoantigens that trigger hypersensitivity reactions (Redlich, 2010).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive isocyanate species.